We are live on ! Find out more
PLX icon

Protalix BioTherapeutics
PLX

19 hedge funds and large institutions have $14.1M invested in Protalix BioTherapeutics in 2020 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,950% more call options, than puts

Call options by funds: $123K | Put options by funds: $6K

566% more capital invested

Capital invested by funds: $2.12M → $14.1M (+$12M)

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

36.07% more ownership

Funds ownership: 4.36% → 40.43% (+36%)

27% more funds holding

Funds holding: 15 → 19 (+4)

Holders
19
Holders Change
+4
Holders Change %
+26.67%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
1
Closed
1
Calls
$123K
Puts
$6K
Net Calls
+$117K
Net Calls Change
+$109K

Top Buyers

Rank Fund Capital Flow
1
HCM
Highbridge Capital Management
New York
+$16M
2
PVH
Psagot Value Holdings
Israel
+$1.34M
3
BCM
Bridgeway Capital Management
Texas
+$296K
4
Renaissance Technologies
Renaissance Technologies
New York
+$58.9K
5
Jane Street
Jane Street
New York
+$58K

Top Sellers

Rank Fund Capital Flow
1
California Public Employees Retirement System
California Public Employees Retirement System
California
-$44.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
1
Highbridge Capital Management
New York
$11.3M +$16M +4,828,974 New
Renaissance Technologies
2
Renaissance Technologies
New York
$1.12M +$58.9K +17,800 +4%
PVH
3
Psagot Value Holdings
Israel
$955K +$1.34M +406,255 +406,255%
BCM
4
Bridgeway Capital Management
Texas
$210K +$296K +89,492 New
California Public Employees Retirement System
5
California Public Employees Retirement System
California
$157K -$44.5K -13,459 -17%
Jane Street
6
Jane Street
New York
$124K +$58K +17,528 +53%
MWPCG
7
Measured Wealth Private Client Group
New Hampshire
$90K – – –
SG Americas Securities
8
SG Americas Securities
New York
$53K – – –
Federated Hermes
9
Federated Hermes
Pennsylvania
$14K – – –
Group One Trading
10
Group One Trading
Illinois
$14K +$2.31K +700 +13%
Victory Capital Management
11
Victory Capital Management
Texas
$12K +$17K +5,140 New
FDCDDQ
12
Federation des caisses Desjardins du Quebec
Quebec, Canada
$2.58K – – –
Royal Bank of Canada
13
Royal Bank of Canada
Ontario, Canada
$1K – – –
CA
14
Clearstead Advisors
Ohio
$1K +$1.65K +500 New
Bank of America
15
Bank of America
North Carolina
– +$103 +31 New
UBS Group
16
UBS Group
Switzerland
– +$427 +129 +258%

PLX Hedge Fund Activity: Q1 2020 in Review

19 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Protalix BioTherapeutics (PLX) for Q1 2020, worth a combined $14.1M — up 566% from $2.12M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new PLX positions and 1 closed out — a net gain of 4 holders — while 5 added to existing stakes and 1 trimmed.

The largest buyer was Highbridge Capital Management, opening a new position worth an estimated $16M. The largest seller was California Public Employees Retirement System, cutting an estimated $44.5K.

  • 19 institutional investors held Protalix BioTherapeutics (PLX) as of Q1 2020, up from 15 in Q4 2019.
  • Funds reported $14.1M of Protalix BioTherapeutics stock for Q1 2020, up 566% quarter-over-quarter.
  • 5 funds opened new Protalix BioTherapeutics positions in Q1 2020 and 1 closed out, a net change of +4 holders.
  • The largest Protalix BioTherapeutics buyer in Q1 2020 was Highbridge Capital Management, an estimated $16M added.
  • The largest Protalix BioTherapeutics seller in Q1 2020 was California Public Employees Retirement System, an estimated $44.5K sold.

Based on aggregated 13F filings for Q1 2020.